Abortion Case Could Harm Womens’ Health and Upset Pharma Markets

Professor Wendy Parmet, faculty director of Northeastern Law’s Center for Health Policy and Law, says the Supreme Court’s decision on access to the mifepristone abortion pill could have significant effects on reproductive health and the pharmaceutical industry.